- Home
- VANI vs FCNCP Comparison
VANI vs FCNCP Comparison
Compare VANI & FCNCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VANI
- FCNCP
- Stock Information
- Founded
- VANI 1998
- FCNCP N/A
- Country
- VANI United States
- FCNCP United States
- Employees
- VANI 36
- FCNCP 16021
- Industry
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- FCNCP Major Banks
- Sector
- VANI Health Care
- FCNCP Finance
- Exchange
- VANI Nasdaq
- FCNCP Nasdaq
- Market Cap
- VANI 75.2M
- FCNCP N/A
- IPO Year
- VANI 2014
- FCNCP N/A
- Fundamental
- Price
- VANI $1.40
- FCNCP $21.01
- Analyst Decision
- VANI Strong Buy
- FCNCP
- Analyst Count
- VANI 1
- FCNCP 0
- Target Price
- VANI $4.00
- FCNCP N/A
- AVG Volume (30 Days)
- VANI 134.3K
- FCNCP N/A
- Earning Date
- VANI 08-12-2025
- FCNCP N/A
- Dividend Yield
- VANI N/A
- FCNCP N/A
- EPS Growth
- VANI N/A
- FCNCP N/A
- EPS
- VANI N/A
- FCNCP N/A
- Revenue
- VANI N/A
- FCNCP N/A
- Revenue This Year
- VANI N/A
- FCNCP N/A
- Revenue Next Year
- VANI N/A
- FCNCP N/A
- P/E Ratio
- VANI N/A
- FCNCP N/A
- Revenue Growth
- VANI N/A
- FCNCP N/A
- 52 Week Low
- VANI $0.91
- FCNCP N/A
- 52 Week High
- VANI $1.50
- FCNCP N/A
- Technical
- Relative Strength Index (RSI)
- VANI 74.26
- FCNCP 41.94
- Support Level
- VANI $1.26
- FCNCP $21.05
- Resistance Level
- VANI $1.30
- FCNCP $21.68
- Average True Range (ATR)
- VANI 0.06
- FCNCP 0.28
- MACD
- VANI 0.00
- FCNCP -0.07
- Stochastic Oscillator
- VANI 69.70
- FCNCP 0.00
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.
About FCNCP First Citizens BancShares Inc.
First Citizens BancShares Inc is the bank holding company of First Citizens Bank & Trust Company. FCB was founded as the Bank of Smithfield in North Carolina and has expanded through both de novo branching and acquisitions. FCB currently operates in nearly half of the continental United States, but principally takes deposits in the Carolinas. The bank's operations have historically been influenced by the Holding family, which has traditionally held executive and director positions, as well as controlling a large percentage of its outstanding stock. FCB provides a wide range of retail and commercial banking services, including traditional lending and deposit-taking, as well as trust and wealth management. FCB's main source of revenue is net interest income.